Pharmacology News

A decrease in hip fractures among adults born more recently may be due to improved lifestyle factors such as reduced smoking and less heavy drinking, according to a study published in JAMA Internal Medicine.

The FDA announced that drug manufacturers will now be required to include information about naloxone in prescribing information for opioids and medications to treat opioid use disorders.

Patients with influenza-like illness who tested positive for coronaviruses besides SARS-CoV-2 and received oseltamivir plus usual care recovered faster than patients who received only usual care, according to researchers.

A blood test to assess C-reactive protein levels in patients with COVID-19 may help determine who would benefit from treatment with glucocorticoid and who would not, according to a study published in the Journal of Hospital Medicine.

Prazosin, approved in the 1970s to control hypertension and used off-label to eliminate PTSD-related nightmares, was recently shown to prevent post-traumatic headaches in veterans in a small randomized controlled trial.

Inhaled interferon beta lowered the risk for developing severe infection and improved the likelihood of recovery from COVID-19 compared with placebo, according to early data released by Synairgen.

A reduced dose of prasugrel in patients with ACS maintained its anti-ischemic effect without elevated bleeding risk compared with patients treated with a standard dose of ticagrelor, regardless of age or weight, researchers found.

In patients with knee osteoarthritis, placebo followed by cognitive behavioral therapy were inferior to meloxicam, according to research published in JAMA Internal Medicine.

Unpasteurized, or raw, milk can serve as a reservoir for antimicrobial-resistant genes, according to a study published in Microbiome.

Certain cardiovascular risk factors in midlife were associated with accelerated cognitive decline, according to a study published in Neurology, the medical journal of the American Academy of Neurology.